Boothbay Fund Management’s iShares Biotechnology ETF IBB Stock Holding History

Boothbay Fund Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,866	Closed	-$895K	–	2433
2022 Q1	$895K	Sell	6,866 -17,455	-72%	-$2.27M	0.02%	964
2021 Q4	$3.71M	Buy	24,321 +21,681	+821%	+$3.36M	0.09%	278
2021 Q3	$427K	Buy	+2,640	New	+$444K	0.01%	1159
2021 Q2	–	Sell	-1,434	Closed	-$216K	–	1961
2021 Q1	$216K	Buy	+1,434	New	+$228K	0.01%	1335
2017 Q4	–	Sell	-10,500	Closed	-$1.17M	–	755
2017 Q3	$1.17M	Buy	+10,500	New	+$1.12M	0.19%	131
2017 Q1	–	Sell	-5,310	Closed	-$508K	–	843
2016 Q4	$470K	Buy	+5,310	New	+$483K	0.11%	250
2015 Q4	–	Sell	-3,750	Closed	-$379K	–	611
2015 Q3	$379K	Buy	+3,750	New	+$450K	0.18%	125

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Boothbay Fund Management's IBB Position: Q2 2022 in Review

Boothbay Fund Management sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 6,866 shares — an estimated $895K sold.

Boothbay Fund Management first reported a position in IBB in Q3 2015 and held it in 7 quarters. The position peaked at $3.71M in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Boothbay Fund Management reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 6,866 iShares Biotechnology ETF shares in Q2 2022, an estimated $895K.
Boothbay Fund Management first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 7 quarters.
Boothbay Fund Management's iShares Biotechnology ETF position peaked at $3.71M in Q4 2021.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.